Insiders Sold These Stocks on Feb-24FyxnewsAlexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, transplan…
Secondhand Smoke Causes Transplant RejectiondailyRxIn a recent study presented by the American Journal of Transplantation, researchers found that mice that were exposed to secondhand smoke (SHS) four weeks before receiving a graft transplant rejected t…
Cigarette smoke exposure results in allograft rejectionNews-Medical.netThese findings for the first time revealed an immunological mechanism underlying allograft rejection precipitated by the exposure to cigarette smoke. "Many people are not aware…
Secondhand smoke results in graft rejectionMedical XpressThese findings for the first time revealed an immunological mechanism underlying allograft rejection precipitated by the exposure to cigarette smoke. "Many people are not aware of the gradua…
Rigel Announces Participation at Two Investor ConferencesSacramento Bee… SYK inhibitor that has completed Phase 1 clinical trials for asthma, R548, an oral JAK3 inhibitor for the treatment of transplant rejection and other immune disorders, and R333,…
UBS AG Analysts Upgrade Alexion Pharmaceuticals Shares to "Buy" (ALXN)Web Inquirer… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the…
HistoryOrgan Transplants: A Brief HistoryHistoryHe found that skin from a different donor usually caused the procedure to fail, observing the immune response that his successors would come to recognize as transplant rejection. European doctors attempte…
RTT NewsPigs As Organ Donors? Maybe SomedayRTT NewsTransplantation of organs from genetically modified pigs into non-human primates is now not substantially limited by hyperacute, acute antibody-mediated, or cellular rejection, but other issues have be…
Take two aspirin and text me in the morningNJBIZAfter a year of using the texting service, only 2 of the 41 study participants had an acute rejection episode, compared to 12 the previous year. Dr. Jeffrey Carson, the Richard C. Reynolds Professor of Me…
Challenges and Solutions to Immunosuppressant TherapyDrug Discovery & DevelopmentThe primary efficacy endpoint was a composite of death, graft failure, biopsy-proven acute rejection (BPAR) via a local pathology reading or loss to follow-up within 12 mo…